Eidos Therapeutics’ $2.83 Billion Merger with BridgeBio Pharma

On September 24, 2020, Amentum Holdings LLC (“Amentum”), a leading contractor to U.S. federal and allied governments jointly owned by Lindsay Goldberg and American Securities, and DynCorp International (“DynCorp”), a worldwide leader in aviation and logistics support services, announced a definitive agreement under which an affiliate of Amentum will acquire DynCorp. The acquisition, once finalized, will create one of the largest providers of mission‑critical support services, with more than $6 billion of combined revenue over the last 12 months. Cravath is representing Amentum, Lindsay Goldberg and American Securities in connection with the transaction.

On August 22, 2020, the Austria-based binderholz Group, a leading European company for solid wood products and innovative building solutions, announced it had entered into a definitive agreement to purchase substantially all the assets of the Florida‑based sawmill operator Klausner Lumber One, LLC after prevailing in an auction held on August 21, 2020 pursuant to Section 363 of the United States Bankruptcy Code. Klausner Lumber One, LLC is currently in Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware. Cravath is representing binderholz Group in connection with the transaction, which closed on September 21, 2020.

On September 21, 2020, Illumina, Inc. (“Illumina”) and GRAIL announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion. In addition, GRAIL shareholders will receive future payments representing a tiered single digit percentage of certain GRAIL-related revenues. GRAIL, a healthcare company focused on multi-cancer early detection, was founded by Illumina, a global leader in DNA sequencing and array-based technologies, in 2016 and spun out as a standalone company. Cravath is representing Illumina in connection with the transaction.

On September 14, 2020, Scientific Games Corporation (“Scientific Games”) announced that a number of long‑term institutional investors, including gaming industry investor Caledonia, have reached agreement to acquire a 34.9% stake in Scientific Games from MacAndrews & Forbes Incorporated at a price of $28.00 per share. In connection with the transaction, Scientific Games is implementing a series of governance changes and enhancements to reflect its new investor base and continue to position the Company for growth and value creation. Cravath is representing Scientific Games and its Special Committee of the Board of Directors in connection with the transaction.